Matches in SemOpenAlex for { <https://semopenalex.org/work/W3095957599> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W3095957599 abstract "In the randomized controlled TRITON (NCT02558231) study, both initial triple oral (macitentan, tadalafil, selexipag) and initial double oral (macitentan, tadalafil, placebo) therapy improved PVR (primary endpoint; by 54% and 52%) and 6-minute walk distance (secondary endpoint; by 55 and 56 m) at wk 26 in patients with newly diagnosed PAH, with no difference between groups. We analysed the treatment effect on the secondary endpoint of time to first disease progression event (centrally adjudicated) until end of the observation period +7 days and time to all-cause death (post-hoc) until end of the observation period (Cox regression model). Baseline characteristics were balanced between the initial triple (n=123) and initial double therapy (n=124) groups, median follow-up was 77.6 and 75.8 wks, respectively. There was a 41% reduction in the risk of first disease progression event with initial triple vs initial double therapy (hazard ratio 0.59, 95% CI 0.32–1.09, p=0.087; Figure), driven by PAH-related hospitalisation and all-cause death. Adverse events were consistent with known safety profiles of study drugs. Two patients died in the initial triple therapy group and 9 in the initial double therapy group (hazard ratio 0.23, 95% CI 0.05–1.04). Exploratory analysis indicated a signal for improved long-term outcome with initial triple versus initial double therapy." @default.
- W3095957599 created "2020-11-09" @default.
- W3095957599 creator A5014497512 @default.
- W3095957599 creator A5016773092 @default.
- W3095957599 creator A5018226650 @default.
- W3095957599 creator A5025474536 @default.
- W3095957599 creator A5031477165 @default.
- W3095957599 creator A5033758604 @default.
- W3095957599 creator A5056570032 @default.
- W3095957599 creator A5065469571 @default.
- W3095957599 creator A5077135547 @default.
- W3095957599 creator A5088806171 @default.
- W3095957599 creator A5089300668 @default.
- W3095957599 date "2020-09-07" @default.
- W3095957599 modified "2023-10-14" @default.
- W3095957599 title "Long-term outcomes with initial triple oral therapy in pulmonary arterial hypertension (PAH): Insights from TRITON" @default.
- W3095957599 doi "https://doi.org/10.1183/13993003.congress-2020.3969" @default.
- W3095957599 hasPublicationYear "2020" @default.
- W3095957599 type Work @default.
- W3095957599 sameAs 3095957599 @default.
- W3095957599 citedByCount "0" @default.
- W3095957599 crossrefType "proceedings-article" @default.
- W3095957599 hasAuthorship W3095957599A5014497512 @default.
- W3095957599 hasAuthorship W3095957599A5016773092 @default.
- W3095957599 hasAuthorship W3095957599A5018226650 @default.
- W3095957599 hasAuthorship W3095957599A5025474536 @default.
- W3095957599 hasAuthorship W3095957599A5031477165 @default.
- W3095957599 hasAuthorship W3095957599A5033758604 @default.
- W3095957599 hasAuthorship W3095957599A5056570032 @default.
- W3095957599 hasAuthorship W3095957599A5065469571 @default.
- W3095957599 hasAuthorship W3095957599A5077135547 @default.
- W3095957599 hasAuthorship W3095957599A5088806171 @default.
- W3095957599 hasAuthorship W3095957599A5089300668 @default.
- W3095957599 hasConcept C126322002 @default.
- W3095957599 hasConcept C142724271 @default.
- W3095957599 hasConcept C164705383 @default.
- W3095957599 hasConcept C168563851 @default.
- W3095957599 hasConcept C197934379 @default.
- W3095957599 hasConcept C203092338 @default.
- W3095957599 hasConcept C204787440 @default.
- W3095957599 hasConcept C207103383 @default.
- W3095957599 hasConcept C27081682 @default.
- W3095957599 hasConcept C2776768464 @default.
- W3095957599 hasConcept C2780816001 @default.
- W3095957599 hasConcept C44249647 @default.
- W3095957599 hasConcept C67761136 @default.
- W3095957599 hasConcept C71924100 @default.
- W3095957599 hasConceptScore W3095957599C126322002 @default.
- W3095957599 hasConceptScore W3095957599C142724271 @default.
- W3095957599 hasConceptScore W3095957599C164705383 @default.
- W3095957599 hasConceptScore W3095957599C168563851 @default.
- W3095957599 hasConceptScore W3095957599C197934379 @default.
- W3095957599 hasConceptScore W3095957599C203092338 @default.
- W3095957599 hasConceptScore W3095957599C204787440 @default.
- W3095957599 hasConceptScore W3095957599C207103383 @default.
- W3095957599 hasConceptScore W3095957599C27081682 @default.
- W3095957599 hasConceptScore W3095957599C2776768464 @default.
- W3095957599 hasConceptScore W3095957599C2780816001 @default.
- W3095957599 hasConceptScore W3095957599C44249647 @default.
- W3095957599 hasConceptScore W3095957599C67761136 @default.
- W3095957599 hasConceptScore W3095957599C71924100 @default.
- W3095957599 hasLocation W30959575991 @default.
- W3095957599 hasOpenAccess W3095957599 @default.
- W3095957599 hasPrimaryLocation W30959575991 @default.
- W3095957599 hasRelatedWork W12515863 @default.
- W3095957599 hasRelatedWork W15367883 @default.
- W3095957599 hasRelatedWork W16927856 @default.
- W3095957599 hasRelatedWork W17026572 @default.
- W3095957599 hasRelatedWork W17535837 @default.
- W3095957599 hasRelatedWork W19828412 @default.
- W3095957599 hasRelatedWork W21478844 @default.
- W3095957599 hasRelatedWork W5032858 @default.
- W3095957599 hasRelatedWork W5864417 @default.
- W3095957599 hasRelatedWork W6918129 @default.
- W3095957599 isParatext "false" @default.
- W3095957599 isRetracted "false" @default.
- W3095957599 magId "3095957599" @default.
- W3095957599 workType "article" @default.